Alumis ALMS
NASDAQ ALMS
$6.62 +0.22 (+3.44%)
At close: Nov 11, 2026 · 4:00 PM EST

Alumis (ALMS) Net Income (2023 - 2026)

Updated

Alumis (ALMS) posted Net Income of -$142.18 million for Q2 2026, compared with $59.36 million a year earlier.

Analysis

Alumis (ALMS) Net Income (2023 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Net Income at Alumis was -$286.5 million; for FY2025, it came in at -$243.29 million.

  • In prior years, Alumis' Net Income was -$294.23 million in FY2024 and -$158.17 million in FY2023.
  • The Q2 2026 figure stands as the lowest quarterly Net Income in data going back to Q2 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 6.45 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 210.00 Mn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 4.22 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 5.07 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 3.12 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 3.86 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 2.43 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 3.25 Bn
10 Alumis 796.45 Mn -915.01 Mn - -142.22 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -142.22 Mn
Mar 31, 2026 -93.05 Mn
Dec 31, 2025 -92.93 Mn
Sep 30, 2025 -110.75 Mn
Jun 30, 2025 59.32 Mn
Mar 31, 2025 -98.96 Mn
Dec 31, 2024 -94.76 Mn
Sep 30, 2024 -93.12 Mn
Jun 30, 2024 -56.51 Mn
Mar 31, 2024 -49.85 Mn
Dec 31, 2023 -39.30 Mn
Sep 30, 2023 -43.38 Mn
Jun 30, 2023 -36.71 Mn
API Access

Alumis Net Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-income&ticker=ALMS&period=max&api_key=YOUR_API_KEY